On December 30, 2005, Vertex Pharmaceuticals (VRTX) had a market capitalization of $3B, based on 107.44M shares at a price of $27.67.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2005 | $27.67 | 22,934,947 | 107,440,000 | $2,972,864,800.00 |
November 2005 | $25.50 | 32,860,567 | 107,440,000 | $2,739,720,000.00 |
October 2005 | $22.75 | 38,589,099 | 107,440,000 | $2,444,260,000.00 |
September 2005 | $22.35 | 24,614,984 | 94,590,000 | $2,114,086,500.00 |
August 2005 | $18.40 | 33,333,913 | 94,590,000 | $1,740,456,000.00 |
July 2005 | $15.95 | 24,759,349 | 94,590,000 | $1,508,710,500.00 |
June 2005 | $16.85 | 41,164,389 | 82,274,000 | $1,386,316,900.00 |
May 2005 | $13.92 | 59,230,140 | 82,274,000 | $1,145,254,080.00 |
April 2005 | $9.53 | 11,531,418 | 82,274,000 | $784,071,220.00 |
March 2005 | $9.36 | 12,081,808 | 79,428,000 | $743,446,080.00 |
February 2005 | $11.54 | 11,817,855 | 79,428,000 | $916,599,120.00 |
January 2005 | $10.17 | 13,532,211 | 79,428,000 | $807,782,760.00 |
December 2004 | $10.57 | 12,319,664 | 79,428,000 | $839,553,960.00 |
November 2004 | $10.62 | 12,201,270 | 79,428,000 | $843,525,360.00 |
October 2004 | $10.88 | 13,630,591 | 79,428,000 | $864,176,640.00 |
September 2004 | $10.50 | 14,641,838 | 78,742,000 | $826,791,000.00 |
August 2004 | $9.73 | 10,472,083 | 78,742,000 | $766,159,660.00 |
July 2004 | $9.23 | 13,021,115 | 78,742,000 | $726,788,660.00 |
June 2004 | $10.84 | 19,243,782 | 78,807,000 | $854,267,880.00 |
May 2004 | $8.80 | 17,426,923 | 78,807,000 | $693,501,600.00 |
April 2004 | $8.64 | 16,075,685 | 78,807,000 | $680,892,480.00 |
March 2004 | $9.42 | 15,476,635 | 78,094,000 | $735,645,480.00 |
February 2004 | $11.27 | 27,533,876 | 78,094,000 | $880,119,380.00 |
January 2004 | $9.91 | 16,212,934 | 78,094,000 | $773,911,540.00 |
December 2003 | $10.35 | 14,747,164 | 78,094,000 | $808,272,900.00 |
